Mereo BioPharma vs Soligenix, Inc.

Mereo BioPharma

Mereo BioPharma is a clinical-stage company focused on developing & commercialising rare disease & oncology treatments

45 employees · est. 2015 · London, United Kingdom

Soligenix, Inc.

We are a late-stage biopharmaceutical company focused on developing & commercializing products to treat rare diseases

27 employees · est. 1987 · Princeton, United States

Soligenix, Inc. is the older company (2015 vs 1987).

Side-by-Side Comparison

Metric	Mereo BioPharma	Soligenix, Inc.
Founded
Founded	2015	1987 older
Headquarters
Headquarters	London, United Kingdom	Princeton, United States
Employees
Employees	45	27
Industry
Industry	Biopharma, Biotechnology, Health Care	Biopharma, Biotechnology, Health Care
Funding Stage
Funding Stage	Post-IPO Equity	Post-IPO Equity
Total Funding
Total Funding	$373.90M	$55.97M
Funding Rounds
Funding Rounds	6	15
Taxonomy
Taxonomy	Mereo BioPharmaBiopharmaceutical CompanyOncology TherapeuticsRare Disease TherapeuticsEtigilimabSetrusumab +9	Biopharmaceutical CompanyRare DiseasesPhotodynamic TherapyVaccine DevelopmentOncologyGastrointestinal Disorders +8
Website
Website	mereobiopharma.com	soligenix.com

About Mereo BioPharma

Mereo Biopharma is a clinical-stage company focused on developing and commercializing rare disease and oncology treatments. Since its founding in 2015, the company has demonstrated an agile and purpose-driven approach to bring novel therapies to market. Through acquisitions from Novartis and AstraZe...

View Full Profile Alternatives

About Soligenix, Inc.

Soligenix: A late-stage biopharmaceutical company, was founded in 1987. The company's slogan emphasizes its focus on developing and commercializing products to treat rare diseases. Soligenix's Specialized BioTherapeutics business segment is currently working on HyBryte™ (SGX301) for the treatment of...

View Full Profile

Also comparing in this category

Comparing more than these two?

Get Mereo BioPharma, Soligenix, Inc. and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Mereo BioPharma compare?

A PDF of Mereo BioPharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

Mereo BioPharma was founded in 2015, based in London, United Kingdom, with 45 employees. Mereo Biopharma is a clinical-stage company focused on developing and commercializing rare disease and oncology treatments. Since its founding in 2015, the company has demonstrated an agile and purpos. Soligenix, Inc. was founded in 1987, based in Princeton, United States, with 27 employees. Soligenix: A late-stage biopharmaceutical company, was founded in 1987. The company's slogan emphasizes its focus on developing and commercializing products to treat rare diseases. Soligenix's Special.

Mereo BioPharma has raised $373.90M and Soligenix, Inc. $55.97M. Latest stage: Mereo BioPharma Post-IPO Equity, Soligenix, Inc. Post-IPO Equity.

Both work in Biopharma, Biotechnology and Health Care and list biopharmaceutical company among their focus areas.

Compare Mereo BioPharma with someone else

Start typing a company name or domain.

Related Comparisons

Mereo BioPharma Alternatives All Companies All Signals

Compiled from the BounceWatch company index. We last looked at Mereo BioPharma on 11 Sep 2024, and Soligenix, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.